Oculis Holding AG (OCS) Total Liabilities (2021 - 2026)
Oculis Holding AG (OCS) recorded quarterly Total Liabilities of $60.5 million in Q1 2026, up 21.13% quarter-over-quarter from $49.9 million in Q4 2025, and up 30.84% on a YoY basis from $46.2 million in Q1 2025.
Oculis Holding AG (OCS) Total Liabilities (2021 - 2026) Analysis & Trends
Oculis Holding AG's Total Liabilities history runs 6 years deep, the most recent figure standing at $60.5 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 30.84% year-over-year to $60.5 million; the TTM figure through Mar 2026 stood at $60.5 million (up 30.84% YoY), while the FY2025 annual figure was $49.9 million, down 6.91% from the prior year.
- Total Liabilities was $60.5 million for Q1 2026 at Oculis Holding AG, up from $49.9 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $140.2 million in Q4 2022 to a low of $19.6 million in Q2 2023.
- Historically, Total Liabilities has averaged $46.1 million across 5 years, with a median of $46.2 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities plunged 83.41% in 2023, then soared 130.6% in 2024.
- A 5-year view of Total Liabilities shows it stood at $140.2 million in 2022, then tumbled by 83.41% to $23.3 million in 2023, then jumped by 130.6% to $53.6 million in 2024, then decreased by 6.91% to $49.9 million in 2025, then advanced by 21.13% to $60.5 million in 2026.
- The last three Total Liabilities figures came in at $60.5 million (Q1 2026), $49.9 million (Q4 2025), and $46.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 137.56 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 60.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.46 Mn |
| Dec 31, 2025 | 49.91 Mn |
| Sep 30, 2025 | 46.56 Mn |
| Jun 30, 2025 | 46.53 Mn |
| Mar 31, 2025 | 46.21 Mn |
| Dec 31, 2024 | 53.62 Mn |
| Sep 30, 2024 | 35.06 Mn |
| Jun 30, 2024 | 28.65 Mn |
| Mar 31, 2024 | 22.55 Mn |
| Dec 31, 2023 | 23.25 Mn |
| Sep 30, 2023 | 26.42 Mn |
| Jun 30, 2023 | 19.63 Mn |
| Dec 31, 2022 | 140.19 Mn |
| Dec 31, 2021 | 129.05 Mn |